Paul Tudor Jones Cv Rx, Inc. Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Cv Rx, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 63,482 shares of CVRX stock, worth $744,009. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,482
Previous 58,916
7.75%
Holding current value
$744,009
Previous $706,000
20.82%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CVRX
# of Institutions
86Shares Held
14.4MCall Options Held
56.3KPut Options Held
41.8K-
Johnson & Johnson New Brunswick, NJ4.1MShares$48.1 Million11.52% of portfolio
-
Nea Management Company, LLC Timonium, MD2.37MShares$27.8 Million1.6% of portfolio
-
Black Rock Inc. New York, NY876KShares$10.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA824KShares$9.66 Million0.0% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT683KShares$8 Million0.85% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $241M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...